Abstract
Several clinical studies have been conducted into the practicality and safety of regenerative therapy using hESC/iPSC-retinal pigment epithelium (RPE) as a treatment for the diseases including age-related macular degeneration. These studies used either suspensions of RPE cells or an RPE cell sheet. The cells can be injected using a minimally invasive procedure but the delivery of an intended number of cells at an exact target location is difficult; cell sheets take a longer time to prepare, and the surgical procedure is invasive but can be placed at the target area. In the research reported here, we combined the advantages of the two approaches by producing a quickly formed hiPSC-RPE strip in as short as 2 days. The strip readily expanded into a monolayer sheet on the plate, and after transplantation in nude rats, it showed a potency to partly expand with the correct apical/basal polarity in vivo, although limited in expansion area in the presence of healthy host RPE. The strip could be injected into a target area in animal eyes using a 24G canula tip.
Similar content being viewed by others
Introduction
Over the past decade, for retinal degeneration, one therapeutic approach which has attracted considerable interest is the use of ES/iPSC-derived retinal pigment epithelial cells (RPE) for cell-based regenerative therapy1,2,3,4,5,6,7,8. Clinical studies have indicated that this therapeutic approach is generally safe and has some possible efficacy. There have been two major approaches taken in these clinical studies: one using cell suspensions, and the other using an RPE sheet. Each approach has advantages and disadvantages. The transplantation of cell suspensions can utilize ready-to-use cell stocks out of a tube or from a short-term recovery culture, and such cells can be transplanted with minor surgical intervention, although controlling the cell delivery to the exact target area can be difficult, and transplanted cells often leak into the vitreous to form an epiretinal membrane (ERM)5,8. The use of an RPE sheet allows visual confirmation of placement, but the preparation of a sheet requires considerable time and cost, and involves an invasive surgical procedure requiring a large incision in the sclera and neural retina.
We conducted a clinical trial using transplantation of an autologous iPSC-RPE sheet. The transplanted sheet looked rolled immediately after the transplantation, but eventually expanded to cover approximately 1.5 times the area of the original RPE sheet, possibly by flattening of the sheet with possible migration and proliferation of the cells 4,9. This observation gave us an idea that even a strip form of RPEs, that could easily be injected subretinally, may expand to cover a larger area, similar to a small sheet transplantation. This approach may enable precise graft placement at the intended area with minimal back-flow leakage into the vitreous and may allow for supplementation of RPEs in any desired multiple areas of the ocular fundus.
A recent study investigated the mechanics of microtissue morphology by examining the relationship between surface coverage, tissue contractility, and adhesion strength 10. These researchers found that cells with balanced adhesiveness and contractility spontaneously generated spheroid-like tissue structures on a concave surface with a small curvature. Based on this finding, we employed a groove surface with a small curvature of the bottom edge to generate a strip of tissue. Although the fabrication of small tissues requires special techniques such as photolithography, we introduced a fabrication technique combining polydimethylsiloxane (PDMS) soft lithography11,12 and simple three-dimensional (3D) printing 13.
In the present study, we prepared a PDMS-based culture device with narrow grooves, to investigate the formation of hiPSC-RPE strips. We then confirmed that hiPSC-RPE cells could expand from a strip that was plated on a dish, to produce RPEs with characteristics like those before a strip formation. We also investigated whether a strip of hiPSC-RPE could be successfully injected into animal eyes and has a potency to expand with the correct polarity.
Results
Preparation of strip-form hiPSC-RPEs
The protocol for strip preparation using a PDMS-based culture device is summarized in Fig. 1 (see also Figure S1). Human iPSC-RPE cells from the cell line 253G1 were suspended and seeded in each groove in “RPE Maintenance medium”, “RPE cell sheet medium” (F10 medium containing 10% fetal bovine serum) or “mixed medium” with 10 µM Y-27632, an inhibitor of the protein serine/threonine kinase 160ROCK. The strips appeared to be easily collapsed in the sheet medium, but a strip structure was well retained in the maintenance medium and mixed medium (Figure S2A and B). Different numbers of cells (4.5 × 105, 1.5 × 105, and 5 × 104) were seeded on the culture device, and it was observed that the first two conditions could lead to the formation of strips (Figure S2C). An example of a strip formed with 4.5 × 105 of hiPSC-RPEs is shown in Fig. 1E,F. The strips were detached from the groove and loaded on 24G intravenous cannula (Fig. 1G).
Optimization of Y-27632 concentration for hiPSC-RPE strips
The strips formed by 4.5 × 105 and 1.5 × 105 cells were plated in wells. Both types of strips showed an expansion of RPE cells on the non-coated plates. The strips formed with 1.5 × 105 cells lost their initial shape faster than the ones formed with 4.5 × 105 cells, which still retained most of their initial form after two weeks (Fig. 2A and Figure S2D). Therefore, we fixed the initial cell number as 1.5–2 × 105 cells. The initial strip forms were mostly lost when the strip was fragmented (Fig. 2A’).
In our preliminary experiments (Figure S3A), the concentration of Y-27632 appeared to affect the strip texture, with a higher concentration making the strip tighter. We tested the effects on strip formation of concentrations of Y-27632 of 0, 1, 2, 2.5, and 10 μM. hiPSC-RPE (M8 Line) cells were able to form strips at a concentration of 2 μM or higher, but at 0 and 1 μM Y-27632, the strips were not well formed. When plated, strips formed with 10 μM Y-27632 detached easily from non-coated wells, took a longer time to attach to 24-well plates, and were delayed in expansion compared to strips formed with 2–2.5 μM Y-27632 (Figure S3B,C).
We compared strips made with either 2.5 μM or 10 μM Y-27632 (Fig. 2B–G). A strip made with 2.5 μM Y-27632 was visually flat and loose, while one formed with 10 μM Y-27632 looked more tensed (Fig. 2B).
The strip sections were immunostained for tight junction marker ZO-1, and polarity markers human Ezrin (apical), Laminin, and human Collagen type IV (basal) (Fig. 2C). In both type of strip, the tight junction marker ZO-1 was expressed between the cells, and the basal marker Laminin was distributed on the cell surfaces, while the apical marker Ezrin appeared to be localized on the surface of segmented cell clumps. Another basal marker, Collagen type IV, was not clearly expressed, indicating that cell polarity was not clearly defined in these RPE strips.
Cell expansion after plating in non-coated wells was compared between the strips formed with 2.5 and 10 μM Y-27632, using strips from day 2 (Fig. 2D,E) and day 3 (Fig. 2F,G). The strips formed with 2.5 μM Y-27632 tended to attach immediately after plating and start expanding, while the strips formed with 10 μM Y-27632 tended to crumple and moved about for a couple of days before they settled and started expansion.
Reproducibility of strip formation using another hiPSC-RPE line
We tested whether another hiPSC line could form strips. We induced RPE differentiation using the 201B7modFucci line and compared the differentiated RPEs with hiPSC(M8)-RPEs. The hiPSC(201B7modFucci)-RPEs also formed strips similar to hiPSC(M8)-RPEs, but the 201B7modFucci line required 5 μM or higher concentration of Y-27632 to stably form strips (Fig. 3A). The optimal Y-27632 concentration for adhesion/expansion assay was also 5 μM for hiPSC(201B7modFucci)-RPE strips (Figure S3D and E). The cells expanded from the strips of both hiPSC lines showed characteristic pigmentation and a cobblestone-like appearance of RPE cells and expressed ZO-1 and an RPE marker microphthalmia transcription factor (MITF) (Fig. 3B,C). The expression of the RPE-specific marker genes BEST1, RPE65, and RLBP1 was also confirmed by polymerase chain reaction (PCR) in each stage of hiPSC-RPEs before strip formation, in the strip forms, and after expansion from the strips (Fig. 3D). The RPE cells were observed to expand from the strip in a monolayer manner on a plate (Fig. 3E). In order to determine whether the expansion from the strip involved RPE proliferation, the total number of cells 14 days after placing the strip on a plate was compared with the initial cell number in day 2 strips formed from 2 × 105 hiPSC-RPE cells. The total number of expanded cells and the cells in the remaining strip was 5.28 × 105 on average, which was approximately four times the average cell number in the day 2 strip (1.36 × 105), indicating that RPE proliferation contributed to the cell expansion from the strips (day 2 4 strips; expansion from 6 hiPSC(M8)-RPE strips; from 6 hiPSC(201B7modFucci)-RPE strips) (Fig. 3F). The secretion of VEGF and PEDF by the expanded cells and the remaining strip at the same time point were also tested 14 days after placing the strip. Expanded hiPSC-RPEs secreted the same amount of vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) as the cells that were originally used for strip formation (hiPSC(M8)-RPE n = 6 wells and hiPSC(201B7modFucci)-RPE n = 6 wells; pre-strip RPEs of both lines as a control, n = 4 wells) (Fig. 3G).
Replacement of RPEs by mimicked hiPSC-RPE transplantation by cell suspension or an RPE-strip in the in vitro RPE damaged model
In order to investigate the way in which transplantation of hiPSC-RPE strips or cells could compensate for damaged RPEs, we designed an in vitro model of hiPSC-RPE transplantation in the RPE-damaged environment, as shown in Fig. 4A. In brief, an hiPSC-RPE (M8 line) culture in a non-coated 24 well plate was treated with Mitomycin C (MMC) to suppress proliferation, and the central part was scratched on the next day. On the following day, an RPE strip was placed on the scratched portion, or suspended cells (M8Fucci2 line or 201B7modFucci line) were seeded over the scratch, and filling or replacement by “transplanted” RPEs was monitored using IncuCyte (Fig. 4B).
In the control wells with scratch but without cell supplementation, MMC-treated pre-existing RPEs gradually expanded to slowly decrease the defect area. Transplanted RPE cells in suspension rapidly occupied the area of the defect. Cells in RPE strips expanded from the strip until they contacted pre-existing RPEs, at which point the cell expansion from the strip stopped, apparently due to contact inhibition. The average sizes of the defect area and the area occupied by the transplanted RPEs are shown 1, 7, and 28 days after in vitro transplantation in Fig. 4B’ (strip and suspension; n = 5 wells, control; n = 3 wells). With RPE strips, the border between the pre-existing RPEs and transplanted RPEs was identified by the expression of mCherry by the transplanted M8Fucci2 cells or 201B7modFucci hiPSC- RPEs, and by the size of the RPE cells; MMC treated, non-dividing RPEs were generally larger than those expanded from transplanted RPEs (Fig. 4C). The presence of the tight junction marker ZO-1 was observed throughout both the pre-existing and transplanted RPE populations, without interruption across the border between the two populations (Fig. 4D).
The secretion of VEGF (Fig. 4E) and PEDF (Fig. 4F) was also monitored, to estimate the overall RPE function in each well. VEGF secretion was significantly reduced after MMC and a scratch, and was increased after 28 days, in all groups. Following transplantation of a cell suspension, VEGF secretion was almost comparable to that before MMC treatment. PEDF secretion was reduced after MMC treatment and a scratch but following treatment with a strip transplantation, showed no difference after 28 days from the levels produced before MMC. PEDF secretion was significantly increased after 28 days from those after a scratch with cell transplantation but continued to decrease with no cell replacement (n = total number of wells in 2 independent experiments; control n = 4, RPE-strip n = 8, RPE cells n = 7).
Additionally, we confirmed if proliferation of expanding RPE cells from the strip was contact dependent using a similar setting but without MMC treatment on pre-plated RPE. We fixed the RPE strips at three different time points after placing on a plate with or without pre-plated RPE and immunostained them with the proliferation marker Ki67 (Figure S4). Ki67 positive cells were observed around the strip and the margin of the scratched pre-plated cells on day 7 but became sparse by the time the cells reached confluency (n = 2 for each condition).
hiPSC-RPE strip transplantation in nude rats
We transplanted hiPSC-RPE strips formed from 2 × 105 cells with either 2.5 μM or 10 μM Y-27632 in albino nude rats, to test the practicality of handling during the surgical procedure, and graft survival after transplantation. The strips were successfully and stably transplanted subretinally (n = 10 with a 10 μM Y-27632 strip and n = 11 with a 2.5 μM Y-27632 strip) onto the normal RPEs in the host eyes. The grafted hiPSC-RPE strip generally looks partially flat on the fundus image (Micron IV, Phoenix Research Laboratories, Inc.), and the sectional view of the corresponding area obtained using optical coherence tomography imaging (Envisu R2200 VHR, Bioptigen, Inc.) shows a clear RPE-like reflex at the graft surface (Figs. 5A and S5A). The strips stably survived for up to 10 months without any unexpected tumor formation or graft loss, although the presence of healthy RPEs seemed to inhibit the expansion of the transplanted strip (Fig. 5B and Table S1).
The flat part of RPE-strip on color fungus image seemed corresponding to the monolayered RPE cells expanding from the graft strip in histological images (representative images from 2 different eyes presented in Fig. 5C–I and Figures S5A–E). These monolayered cells clearly expressed apical (human Ezrin) and basal (human Collagen type IV) markers, restoring the correct polarity after transplantation (Fig. 5D’,D’’). The original graft RPE-strip was often found multilayered, and the top layer randomly formed a sheet like layer also with the correct polarity (Fig. 5D,D’). These correctly polarized cells, either in a monolayer or in the top layer, also expressed phagocytosis related tyrosin-protein kinase Mer (MERTK) on the apical side and contacted host outer segments that are positive for peripherin (Fig. 5E,E’’) or rhodopsin (Fig. 5F). This suggested the presence of functional interaction between the host photoreceptors and graft RPEs. Although the apical-basal orientation seems correct when they are in a single layer or randomly when in the top layer of the graft, the graft RPEs can also form spheroids where RPE cells express apical marker Ezrin inside, or the polarity is not definite in some multilayered grafts (Figure S5F).
RPE cells in the top layer of the graft sometimes look continuous with host RPEs and contact outer segments of host photoreceptors (Fig. 5G). Monolayered graft RPE cells were also found continuous with host RPE cells and express the tight junction marker ZO-1 on the apical side (Fig. 5H). In order to assess the graft integration more closely, we directly observed the host and graft RPEs by fixing the eye 1 week after transplantation and by removal of host retina followed by ZO-1 staining (Figure S5G). Three-dimensional reconstruction of confocal microscope images implied that, in some grafted area, GFP positive graft RPEs (201B7modFucci line) can partially replace graft RPE cells, and some borderline cells were found migrating beneath the edge of the host cells (Figure S5Ga–c).
In the graft, very few cells were positive for proliferation marker Ki67 (Fig. 5I).
hiPSC-RPE strip injection in rabbit eyes
The practicality of the surgical procedure of hiPSC-RPE strip transplantation in a clinical setting was confirmed using two rabbit eyes. An RPE strip was loaded in a 24G intravenous cannula. After routine vitrectomy, a focal retinal detachment was made, and the strip was successfully injected into the retinal bleb under good visual control. (Fig. 6 and Videos S1).
Discussion
In this study, we succeeded in consistently inducing the formation of RPE strips in as short a period as two days, using different hiPSC-RPE cell lines. These strips were easy to handle and could be loaded into a regular 24G intravenous cannula. Once these RPE strips were placed on a non-coated culture plate, they expanded into a monolayer sheet, which exhibited the same characteristics as the original RPE cells. This observation indicates that these RPE strips could substitute for RPE sheet transplantation. For this purpose, efficient attachment of, and cell expansion from, the strip after transplantation is essential. We found that the concentration of Y-27632 affected the firmness or looseness of the strips, with a higher concentration leading to shrinkage of the strips, resulting in delayed attachment on the plate, as well as delayed expansion of the RPE cells.
The contractility of cells determines microtissue morphology under both constant curvature and adhesion strength. Higher contractility leads to condensation, and lower values lead to bridging and adhering of cells 10,14. In the present study, the PDMS surface seemed to provide low cell adhesiveness to enable cells to detach and condense. The PDMS-based culture device, which had a 0.2-mm curvature radius, was able to provide appropriate physical conditions for the formation and harvesting of RPE strips in a straightforward manner. The addition of Y-27632 generally suppresses contractility 15 and elongates the shape of human RPE 16. In this study, the microgroove appeared to define the direction of cell elongation, resulting in shrinkage of the strip at a higher concentration of Y-27632, as a synergistic effect between physical and pharmacological conditions. The results of experiments using different Y-27632 concentrations suggested that the adjustment of Rho kinase level was an important factor with which to control tissue formation on the concave culture surface, to improve the shape of the strip. It is also noteworthy that each hiPSC-RPE cell line may have a different optimal concentration of Y-27632.
In this study, the expansion of the RPEs from a strip appears to involve both the proliferation and migration of RPE cells, given the increased total number of cells after two weeks of expansion, and as shown by Ki67 positivity around the strip on day 7. In our scratch model experiment, the RPE cells expanded from the strips until they came in contact with resident RPE cells, at which point they appeared to stop proliferation, as again shown by Ki67 positivity, and, interestingly, formed tight junctions with the resident cells as indicated by the ZO-1 staining. This observation suggests that the RPE cells from the strip would fill the RPE defect but are not likely to overgrow. In rat experiments, we did not observe any undesired or unexpected proliferation of the graft strips, and we only observed a limited sheet-like expansion. Poor RPE expansion in vivo was considered to be due to the presence of healthy host RPEs, without any defects. Still, the monolayered graft RPEs and sometimes those in a sheet-like layer on the top of graft tissues showed the correct apical/basal polarity with the expression of phagocytosis-related MERTK on the apical side that contacts host photoreceptor outer segments, suggesting a functional interaction with host photoreceptors. The strip does not have a polarity at the time of transplantation, and it is an advantage that we can simply inject it in a surgical procedure. But this also means that currently we do not have a control over how the RPE graft cells integrate or expand. Graft RPE can also take a wrong orientation when they are multi-layered or formed spheroids. We may have to remove or disrupt the host RPEs in order to facilitate the graft expansion ideally in a monolayer, which routinely presents the correct polarity. We need an appropriate animal model to further investigate how the strip derived RPEs can efficiently expand and replace diseased RPEs in vivo.
In recent clinical studies, hESC/iPSC-RPE transplantation was conducted using either cell suspensions or sheets 1,2,3,4,5,6,7,8. The advantages and disadvantages of the RPE-strip approach as compared with the use of cell suspensions or sheet transplantation are summarized in Table 1. With the RPE strip, we can ensure good graft visibility during surgical procedures such as sheet transplantation, enabling good control of the graft delivery to the targeted site by preventing backflow; simultaneously, we can avoid the use of an invasive procedure, as required to make a large incision for transplantation. The RPE strips may require a supportive matrix scaffold upon which the cells can efficiently expand with the correct polarity. Cell suspension transplantation requires cells to attach and migrate, while a sheet with a scaffold can be placed on any diseased, or even remaining healthy, RPEs. The pattern of desired grafting may also favor different forms of RPEs. For instance, an RPE sheet is most suitable to cover the specific central macular area, but if RPE supplementation is required surrounding the remaining macular area, or on multiple patchy spots, multiple strips would most effectively cover these areas. Also, sheet preparation takes longer than three weeks2,3. The current 2-day RPE strip protocol can thus lead to a reduction in the cost incurred by using a clinical grade cell processing facility.
In conclusion, we could prepare strip-form hiPSC-RPEs, which could potentially be an optional therapeutic approach cost-wise and safety-wise, for treating some diseases involving RPE atrophy.
Materials and methods
All animal experimental protocols were approved by the Animal Care Committee of the RIKEN Center for Biosystems Dynamics Research (BDR) and were conducted in accordance with local guidelines and the ARVO statement on the use of animals in ophthalmic and vision research. Generation of hiPS cells was approved by the ethical committee of the RIKEN Center for Biosystems Dynamics Research (BDR), and informed consent was obtained from the volunteers.
Fabrication of PDMS-based culture device for hiPSC-RPE strip formation
The PDMS-based culture device was made with grooves of 19.5 mm length, 1 mm width, and 1.6 mm depth. The fabrication process of the device is summarized in Fig. 1A. The mold for this device was first fabricated by 3D printing using polylactic acid (PLA) filament. A 3D printed mold was shaved and coated with PDMS to adjust the shape of the grooves, and then a mold-release agent (Novec1720, Sumitomo 3M) was applied to the mold. PDMS and a curing agent for PDMS (Sylpot 184W/C) (Dow Corning Toray) were mixed in a 10: 1 ratio and poured onto the 3D printed mold and degassed for approximately 1 h. The PDMS mixture with the 3D printed mold was then placed in an 80 °C oven for 3 h. The cured PDMS was harvested from the 3D printed mold and trimmed. The curvature radius of the groove bottom was measured using a confocal scanning laser microscope (KEYENCE, VK-8710) as R 0.2 mm (Fig S1).
Preparation of human iPSC (hiPSC) and hiPSC derived RPE cells (hiPSC-RPE)
The M8 human iPSC line was established in our laboratory by introducing six reprogramming factors (OCT3/4, SOX2, KLF4, L-MYC, LIN28, and p53 carboxy-terminal dominant-negative fragment) into peripheral blood mononuclear cells (PBMCs) from a healthy volunteer. We electroporated episomal vectors (pCE-hOCT3/4, pCE -hSK, pCE -hUL, pCE -mp53DD, pCXB-EBNA1 purchased from Addgene) to the PBMCs, and then picked iPSC-like colonies as previously described17. After several passages, we performed PCR analysis using the DNA extracted from the iPSC-like cells to examine whether the episomal vectors were undetectable with plasmid-specific primers (Figure S4).
201B7 and 253G1 hiPSC lines were obtained from Center for iPS Cell Research and Application, Kyoto University18,19. Two Fucci (Fluorescent Ubiquitination-based Cell Cycle Indicator) cell lines were made in our laboratory to visualize G1 and S/G2/M phases (M8Fucci2), and G1 and the whole cell body (201B7modFucci). Briefly, mCherry-hCdt1(30/120)-P2A-mVenus-hGem (1/110) region and mCherry-hCdt1(30/120)-P2A-mVenus region were excised from tFucci(CA)2/pCSII-EF vector (a gift from Dr. A. Miyawaki, https://cfm.brc.riken.jp/lentiviral-vectors/plasmid-list/) and ligated into the pAAVS1-Nst-CAG-DEST vector (Addgene Plasmid #80489) to make Fucci2 and modFucci donor vectors, respectively. M8 and 201B7 line was each transfected with Fucci2 or modFucci donor, respectively, with the Cas9 vector (Addgene Plasmid #62988) encoding gRNA designed to target AAVS1 locus20 using DNA-in CRISPR delivery media (MTI-GlobalStem, Gaithersburg, MD). After transfection, mVenus-positive M8 and 201B7 colonies were dissociated and passaged to pick single clone-oriented colonies (Figure S5).
hiPSC-RPE cells were differentiated using the SFEBq method21,22,23. (See Supplementary methods for details). Between days 30 and 60, pigmented colonies were picked and plated in 12-well plates (Corning Incorporated, Corning, NY) coated with iMatrix 511 (Nippi. Inc., Tokyo, Japan) containing a 1: 1 “Mixed medium” of "RPE adhesion medium" and "RPE maintenance medium". “RPE adhesion medium” contains DMEM/F-12 (Sigma-Aldrich, St. Louis, MO), 10% fetal bovine serum (SAFC Biosciences Inc.), gentamicin solution (Sigma-Aldrich) and “RPE maintenance medium” contains DMEM-low glucose (Sigma-Aldrich), 30% F-12(Sigma-Aldrich), 2% l-glutamine solution (Sigma-Aldrich), 2% B-27™ Supplement (50×) (Thermo Fisher Scientific Inc., Waltham, MA), and gentamicin solution (Sigma-Aldrich). Once the cells were attached, the medium was changed to RPE maintenance medium with 10 ng/mL basic fibroblast growth factor (bFGF) (Wako, Osaka, Japan). The cell culture was expanded in the RPE maintenance medium through one passage, and the cells were stocked at − 150 °C using Stem-Cell Banker (Nippon Zenyaku Kogyo Co., Ltd.).
For each experiment, the stocked cells were thawed and plated with the mixed medium, and then the medium was changed to RPE maintenance medium supplemented with 10 ng/mL bFGF and 0.5 µM SB431542 (Sigma-Aldrich), which was changed every few days until the cells were used. RPE cells differentiated from 253G1 cells were prepared as described previously 24.
Formation of hiPSC-RPE strips
After thawing, hiPSC-RPE cells were cultured for two weeks, and then collected and plated in each groove of the PDMS-based culture device at the cell number described in each experiment, with15 µl RPE maintenance medium containing Y-27632(Wako) (concentration indicated in each experiment).
Analysis of expansion area of RPEs from a plated hiPSC-RPE strip
hiPSC-RPE strips were released from a groove in the device and placed on non-coated 24-well plates (Corning) with a strip/well in mixed medium, that was changed to RPE maintenance medium with bFGF and SB431542 after strip attachment two to three days later. The dishes in culture were photographed using an IncuCyte Zoom system (Essen BioScience). From the image data, expanded cells were manually marked with Fiji image analysis software, and the expanded area was measured.
In vitro RPE damaged model
Confluent RPE cultures in 24-well plates were treated with MitomycinC (Kyowa Hakko Kirin, Tokyo, Japan) at 6 µg/mL. On the following day, a band of RPE cells was scratched and removed using a cell scraper of approximately 6 mm width. hiPSC-RPEs of either cell suspension (2 × 10^5) or of a strip form was plated (“transplanted”) over or in the scratched RPE area. The cells were maintained in 0.5 ml medium and were collected for ELISA at the time of each intervention, with 24 h incubation before medium change. The schedule of the experiment plans and the timing of medium collection are shown in Fig. 4A.
ELIZA for VEGF and PEDF
VEGF and PEDF were performed according to the manufacturer’s protocol of the VEGF Human ELISA Kits (Invitrogen, Thermo Fisher Scientific Inc., Waltham, MA) and Human PEDF ELISA Kits (BioVendor, Brno, Czech Republic), respectively.
Transplantation in rat eyes
Immune-deficient F344/NJc1-rnu/rnu female nude rats, six weeks old, were obtained from CLEA Japan. Disposable micropipettes (1-000-0500, Drummon, Alabama, USA) were pulled using a micropipette puller (P-97/IVF Puller, Sutter Instrument, California, USA), and the tip was cut and sharpened using a microgrinder (EG-400, Narishige, Tokyo, Japan). The micropipettes were then adapted to a microelectrode holder (MPH310, World Precision Instruments., FL, USA) on a 6.3 mm electrode handle (2505, World Precision Instruments.), connected to a 10 µl micro-syringe (1701LT, Hamilton, MA, USA) with an extension tube. The animals were anesthetized by inhalation of 5% isoflurane in air, and the eyes were dilated with 0.4% tropicamide. The hiPSC-RPE strip was loaded in a micropipette and the strip was transplanted subretinally.
Transplantation in rabbit eyes
kbl:JW rabbits, nine weeks old, were obtained from Oriental Yeast Co., Tokyo. The animals were anesthetized by intramuscular injection of 60 mg/kg ketamine and 10 mg/kg xylazine. After a routine vitrectomy with posterior vitreous detachment, the iPSC-RPE strip was loaded into the outer tube of a 24-gauge indwelling needle cannula (SS-6, TOP Corporation, Tokyo, Japan) supported by a custom-made flat-cut 25G needle inside. A focal retinal detachment was made with a PolyTip Cannula 25 g/38 g (MedOne, FL, USA), and the graft strip was slowly injected into the detached retinal bleb using a 50 µl micro-syringe (1705LT, Hamilton). Then, perfluorocarbon liquid (8065900111, Alcon, Inc., Geneva, Switzerland) was injected over the detachment to press and attach to the retina, followed by fluid-gas exchange.
References
Brant Fernandes, R. A. et al. Development of a new tissue injector for subretinal transplantation of human embryonic stem cell derived retinal pigmented epithelium. Int. J. Retina Vitreous 3, 1–9 (2017).
Da Cruz, L. et al. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nat. Biotechnol. 36, 1–10 (2018).
Kashani, A. H. et al. A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration. Sci. Transl. Med. 10, 1–11 (2018).
Mandai, M. et al. Autologous induced stem-cell-derived retinal cells for macular degeneration. N. Engl. J. Med. 376, 1038–1046 (2017).
Schwartz, S. D. et al. Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet 379, 713–720 (2012).
Schwartz, S. D. et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: Follow-up of two open-label phase 1/2 studies. Lancet 385, 509–516 (2015).
Song, W. K. et al. Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: Preliminary results in Asian patients. Stem Cell Rep. 4, 860–872 (2015).
Sugita, S. et al. HLA-matched allogeneic iPS cells-derived RPE transplantation for macular degeneration. J. Clin. Med. 9, 2217 (2020).
Takagi, S. et al. Evaluation of transplanted autologous induced pluripotent stem cell-derived retinal pigment epithelium in exudative age-related macular degeneration. Ophthalmol. Retin. 3, 850–859 (2019).
Yamashita, T., Kollmannsberger, P., Mawatari, K., Kitamori, T. & Vogel, V. Cell sheet mechanics: How geometrical constraints induce the detachment of cell sheets from concave surfaces. Acta Biomater. 45, 85–97 (2016).
Xia, Y. & Whitesides, G. M. Soft lithography. Angew. Chem. Int. Ed. 37, 550–575 (1998).
Xia, Y. & Whitesides, G. M. Soft lithography. Annu. Rev. Mater. Sci. 28, 153–184 (1998).
Kamei, K. I. et al. 3D printing of soft lithography mold for rapid production of polydimethylsiloxane-based microfluidic devices for cell stimulation with concentration gradients. Biomed. Microdev. 17, 36 (2015).
Tanaka, N. et al. An ultra-small fluid oscillation unit for pumping driven by self-organized three-dimensional bridging of pulsatile cardiomyocytes on elastic micro-piers. Sens. Actuators B Chem. 293, 256–264 (2019).
Takebe, T. et al. Vascularized and complex organ buds from diverse tissues via mesenchymal cell-driven condensation. Cell Stem Cell 16, 556–565 (2015).
Ni, Y., Qin, Y., Fang, Z. & Zhang, Z. ROCK inhibitor Y-27632 promotes human retinal pigment epithelium survival by altering cellular biomechanical properties. Curr. Mol. Med. 17, 637–646 (2017).
Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409–412 (2011).
Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101–106 (2008).
Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
Oceguera-Yanez, F. et al. Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives. Methods 101, 43–55 (2016).
Nakano, T. et al. Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 10, 771–785 (2012).
Kuwahara, A. et al. Generation of a ciliary margin-like stem cell niche from self-organizing human retinal tissue. Nat. Commun. 6, 13 (2015).
Kuwahara, A. et al. Preconditioning the initial state of feeder-free human pluripotent stem cells promotes self-formation of three-dimensional retinal tissue. Sci. Rep. 9, 1–16 (2019).
Kitahata, S. et al. Critical functionality effects from storage temperature on human induced pluripotent stem cell-derived retinal pigment epithelium cell suspensions. Sci. Rep. 9, 1–15 (2019).
Acknowledgements
We thank Dr. A. Miyawaki for providing us with the tFucci (CA)2/pCSII-EF vector. This work was conducted under Organoid Project, RIKEN BDR.
Author information
Authors and Affiliations
Contributions
M.M. and M.T. conceived the study. M.N. conducted all the in vitro experiments using RPEs and immunohistology. Yu.T., Yo.T., S.A., and N.T. designed and made the PDMS-based device. T.M. and A.O. produced the hiPS cell lines. M.M. conducted transplantation surgeries in animals. H.U., J.S., and S.Y. conducted in vivo imaging of animal eyes, and supported the animal experiments. M.N. and M.M. analyzed and interpreted the data. M.N., M.M., and N.T. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Supplementary Video S1.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Nishida, M., Tanaka, Y., Tanaka, Y. et al. Human iPS cell derived RPE strips for secure delivery of graft cells at a target place with minimal surgical invasion. Sci Rep 11, 21421 (2021). https://doi.org/10.1038/s41598-021-00703-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-021-00703-x
- Springer Nature Limited
This article is cited by
-
Graft cell expansion from hiPSC-RPE strip after transplantation in primate eyes with or without RPE damage
Scientific Reports (2024)
-
Stem cell sources and characterization in the development of cell-based products for treating retinal disease: An NEI Town Hall report
Stem Cell Research & Therapy (2023)